Fertility and sterility · 2011
Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Panidis Dimitrios, Tziomalos Konstantinos, Macut Djuro, Delkos Dimitrios, Betsas George, Misichronis Georgios, Katsikis Ilias
Аннотация
OBJECTIVE: To assess the effects of age on the hormonal, metabolic, and ultrasonographic features of polycystic ovary syndrome (PCOS).
DESIGN: Observational study.
SETTING: University department of obstetrics and gynecology.
PATIENT(S): Patients with PCOS (n = 1,212) and healthy women (n = 254).
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Differences in the hormonal, metabolic, and ultrasonographic features of PCOS between age groups.
RESULT(S): A progressive decline in circulating androgens was observed with advancing age. Patients 21-30 years old had lower plasma glucose and insulin levels, lower area under the oral glucose tolerance test curve and lower homeostasis model assessment of insulin resistance index, and higher glucose/insulin and quantitative insulin sensitivity check index than patients 31-39 years old. The prevalence of PCOS phenotypes changed with age. More specifically, the distribution of the phenotypes did not differ substantially between patients ≤ 20 years old and patients 21-30 years old. However, a decline in the prevalence of phenotype 1 (characterized by anovulation, hyperandrogenemia, and polycystic ovaries) and an increase in the prevalence of phenotype 4 (characterized by anovulation and polycystic ovaries without hyperandrogenemia) were observed in patients 31-39 years old.
CONCLUSION(S): In women with PCOS, hyperandrogenemia appears to diminish during reproductive life whereas insulin resistance worsens.
DESIGN: Observational study.
SETTING: University department of obstetrics and gynecology.
PATIENT(S): Patients with PCOS (n = 1,212) and healthy women (n = 254).
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): Differences in the hormonal, metabolic, and ultrasonographic features of PCOS between age groups.
RESULT(S): A progressive decline in circulating androgens was observed with advancing age. Patients 21-30 years old had lower plasma glucose and insulin levels, lower area under the oral glucose tolerance test curve and lower homeostasis model assessment of insulin resistance index, and higher glucose/insulin and quantitative insulin sensitivity check index than patients 31-39 years old. The prevalence of PCOS phenotypes changed with age. More specifically, the distribution of the phenotypes did not differ substantially between patients ≤ 20 years old and patients 21-30 years old. However, a decline in the prevalence of phenotype 1 (characterized by anovulation, hyperandrogenemia, and polycystic ovaries) and an increase in the prevalence of phenotype 4 (characterized by anovulation and polycystic ovaries without hyperandrogenemia) were observed in patients 31-39 years old.
CONCLUSION(S): In women with PCOS, hyperandrogenemia appears to diminish during reproductive life whereas insulin resistance worsens.
Предметные рубрики MeSH
AdultAge FactorsAnalysis of VarianceAndrogensAnovulationBiomarkersBlood GlucoseBody Mass IndexCase-Control StudiesChi-Square DistributionCross-Sectional StudiesFemaleGlucose Tolerance TestGreeceHormonesHospitals, UniversityHumansHyperandrogenismInsulinInsulin ResistanceOvaryPhenotypePolycystic Ovary SyndromePrevalenceUltrasonographyYoung Adult